tiprankstipranks
Healthequity Inc (HQY)
NASDAQ:HQY
US Market
HQY
Healthequity
RESEARCH TOOLSreports
Want to see HQY full AI Analyst Report?

Healthequity (HQY) Stock Forecast & Price Target

890 Followers
See the Price Targets and Ratings of:

HQY Analyst Ratings

Strong Buy
11Ratings
Strong Buy
10 Buy
0 Hold
1 Sell
Based on 11 analysts giving stock ratings to
Healthequity
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HQY Stock 12 Month Forecast

Average Price Target

$114.27
▲(32.81% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Healthequity in the last 3 months. The average price target is $114.27 with a high forecast of $128.00 and a low forecast of $88.00. The average price target represents a 32.81% change from the last price of $86.04.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"76":"$76","129":"$129","89.25":"$89.3","102.5":"$102.5","115.75":"$115.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":128,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$128.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":114.27272727272728,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$114.27</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":88,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$88.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[76,89.25,102.5,115.75,129],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.4,85.90769230769232,89.41538461538462,92.92307692307693,96.43076923076923,99.93846153846154,103.44615384615385,106.95384615384616,110.46153846153847,113.96923076923076,117.47692307692307,120.98461538461538,124.49230769230769,{"y":128,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.4,84.85174825174826,87.3034965034965,89.75524475524476,92.20699300699302,94.65874125874126,97.11048951048951,99.56223776223777,102.01398601398603,104.46573426573427,106.91748251748253,109.36923076923077,111.82097902097902,{"y":114.27272727272728,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,82.4,82.83076923076923,83.26153846153846,83.6923076923077,84.12307692307692,84.55384615384615,84.98461538461538,85.41538461538462,85.84615384615385,86.27692307692308,86.70769230769231,87.13846153846154,87.56923076923077,{"y":88,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":87.95,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.81,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.89,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.06,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.85,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.71,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":94.58,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":102.41,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":91.61,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.07,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.93,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.38,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.4,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$128.00Average Price Target$114.27Lowest Price Target$88.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barrington Analyst forecast on HQY
Alexander Paris
Barrington
Barrington
$110
Buy
27.85%
Upside
Reiterated
05/29/26
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (NYSE: BDX), Agios Pharma (NASDAQ: AGIO) and Healthequity (NASDAQ: HQY)
Bank of America Securities Analyst forecast on HQY
Allen Lutz
Bank of America Securities
Bank of America Securities
$115→$125
Buy
45.28%
Upside
Reiterated
05/29/26
HealthEquity price target raised to $125 from $115 at BofAHealthEquity price target raised to $125 from $115 at BofA
Barclays Analyst forecast on HQY
Peter Warendorf
Barclays
Barclays
$110
Buy
27.85%
Upside
Reiterated
05/29/26
Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Healthequity (HQY)
Goldman Sachs Analyst forecast on HQY
David Roman
Goldman Sachs
Goldman Sachs
$88
Sell
2.28%
Upside
Reiterated
05/29/26
David Roman Reiterates Sell on HealthEquity as Elevated Expectations and Valuation Skew Risk‑Reward to the Downside
RBC Capital Analyst forecast on HQY
Ryan Halsted
RBC Capital
RBC Capital
$108
Buy
25.52%
Upside
Reiterated
05/29/26
Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Immunovant (IMVT)
Wells Fargo Analyst forecast on HQY
Stan Berenshteyn
Wells Fargo
Wells Fargo
$125
Buy
45.28%
Upside
Reiterated
05/28/26
Analysts' Top Healthcare Picks: Healthequity (HQY), Teladoc (TDOC)
BTIG Analyst forecast on HQY
David Larsen
BTIG
BTIG
$110
Buy
27.85%
Upside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (NYSE: BHVN) and Healthequity (NASDAQ: HQY)
KeyBanc Analyst forecast on HQY
Scott Schoenhaus
KeyBanc
KeyBanc
$125
Buy
45.28%
Upside
Reiterated
05/26/26
KeyBanc Sticks to Its Buy Rating for Healthequity (HQY)
BMO Capital Analyst forecast on HQY
Sean Dodge
BMO Capital
BMO Capital
$85→$105
Buy
22.04%
Upside
Upgraded
04/09/26
Analysts Conflicted on These Healthcare Names: Amgen (NASDAQ: AMGN) and Healthequity (NASDAQ: HQY)
J.P. Morgan Analyst forecast on HQY
Alexei Gogolev
J.P. Morgan
J.P. Morgan
$123
Buy
42.96%
Upside
Reiterated
03/25/26
Healthequity (HQY) Gets a Buy from J.P. Morgan
Deutsche Bank Analyst forecast on HQY
George Hill
Deutsche Bank
Deutsche Bank
$120→$128
Buy
48.77%
Upside
Reiterated
03/19/26
HealthEquity price target raised to $128 from $120 at Deutsche BankHealthEquity price target raised to $128 from $120 at Deutsche Bank
Jefferies Analyst forecast on HQY
Brian Tanquilut
Jefferies
Jefferies
$120→$108
Buy
25.52%
Upside
Reiterated
02/19/26
HealthEquity price target lowered to $108 from $120 at JefferiesHealthEquity price target lowered to $108 from $120 at Jefferies
Raymond James Analyst forecast on HQY
Gregory Peters
Raymond James
Raymond James
$120→$100
Buy
16.23%
Upside
Reiterated
02/17/26
HealthEquity price target lowered to $100 from $120 at Raymond JamesHealthEquity price target lowered to $100 from $120 at Raymond James
Citizens JMP Analyst forecast on HQY
Constantine Davides
Citizens JMP
Citizens JMP
$117→$122
Buy
41.79%
Upside
Reiterated
12/04/25
HealthEquity price target raised to $122 from $117 at Citizens JMPHealthEquity price target raised to $122 from $117 at Citizens JMP
Mizuho Securities Analyst forecast on HQY
Steven Valiquette
Mizuho Securities
Mizuho Securities
$126
Buy
46.44%
Upside
Reiterated
07/02/25
Mizuho Securities Remains a Buy on Healthequity (HQY)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barrington Analyst forecast on HQY
Alexander Paris
Barrington
Barrington
$110
Buy
27.85%
Upside
Reiterated
05/29/26
Analysts Offer Insights on Healthcare Companies: Becton Dickinson (NYSE: BDX), Agios Pharma (NASDAQ: AGIO) and Healthequity (NASDAQ: HQY)
Bank of America Securities Analyst forecast on HQY
Allen Lutz
Bank of America Securities
Bank of America Securities
$115→$125
Buy
45.28%
Upside
Reiterated
05/29/26
HealthEquity price target raised to $125 from $115 at BofAHealthEquity price target raised to $125 from $115 at BofA
Barclays Analyst forecast on HQY
Peter Warendorf
Barclays
Barclays
$110
Buy
27.85%
Upside
Reiterated
05/29/26
Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Healthequity (HQY)
Goldman Sachs Analyst forecast on HQY
David Roman
Goldman Sachs
Goldman Sachs
$88
Sell
2.28%
Upside
Reiterated
05/29/26
David Roman Reiterates Sell on HealthEquity as Elevated Expectations and Valuation Skew Risk‑Reward to the Downside
RBC Capital Analyst forecast on HQY
Ryan Halsted
RBC Capital
RBC Capital
$108
Buy
25.52%
Upside
Reiterated
05/29/26
Analysts Are Bullish on Top Healthcare Stocks: Allogene Therapeutics (ALLO), Immunovant (IMVT)
Wells Fargo Analyst forecast on HQY
Stan Berenshteyn
Wells Fargo
Wells Fargo
$125
Buy
45.28%
Upside
Reiterated
05/28/26
Analysts' Top Healthcare Picks: Healthequity (HQY), Teladoc (TDOC)
BTIG Analyst forecast on HQY
David Larsen
BTIG
BTIG
$110
Buy
27.85%
Upside
Reiterated
05/28/26
Analysts Offer Insights on Healthcare Companies: Biohaven Ltd. (NYSE: BHVN) and Healthequity (NASDAQ: HQY)
KeyBanc Analyst forecast on HQY
Scott Schoenhaus
KeyBanc
KeyBanc
$125
Buy
45.28%
Upside
Reiterated
05/26/26
KeyBanc Sticks to Its Buy Rating for Healthequity (HQY)
BMO Capital Analyst forecast on HQY
Sean Dodge
BMO Capital
BMO Capital
$85→$105
Buy
22.04%
Upside
Upgraded
04/09/26
Analysts Conflicted on These Healthcare Names: Amgen (NASDAQ: AMGN) and Healthequity (NASDAQ: HQY)
J.P. Morgan Analyst forecast on HQY
Alexei Gogolev
J.P. Morgan
J.P. Morgan
$123
Buy
42.96%
Upside
Reiterated
03/25/26
Healthequity (HQY) Gets a Buy from J.P. Morgan
Deutsche Bank Analyst forecast on HQY
George Hill
Deutsche Bank
Deutsche Bank
$120→$128
Buy
48.77%
Upside
Reiterated
03/19/26
HealthEquity price target raised to $128 from $120 at Deutsche BankHealthEquity price target raised to $128 from $120 at Deutsche Bank
Jefferies Analyst forecast on HQY
Brian Tanquilut
Jefferies
Jefferies
$120→$108
Buy
25.52%
Upside
Reiterated
02/19/26
HealthEquity price target lowered to $108 from $120 at JefferiesHealthEquity price target lowered to $108 from $120 at Jefferies
Raymond James Analyst forecast on HQY
Gregory Peters
Raymond James
Raymond James
$120→$100
Buy
16.23%
Upside
Reiterated
02/17/26
HealthEquity price target lowered to $100 from $120 at Raymond JamesHealthEquity price target lowered to $100 from $120 at Raymond James
Citizens JMP Analyst forecast on HQY
Constantine Davides
Citizens JMP
Citizens JMP
$117→$122
Buy
41.79%
Upside
Reiterated
12/04/25
HealthEquity price target raised to $122 from $117 at Citizens JMPHealthEquity price target raised to $122 from $117 at Citizens JMP
Mizuho Securities Analyst forecast on HQY
Steven Valiquette
Mizuho Securities
Mizuho Securities
$126
Buy
46.44%
Upside
Reiterated
07/02/25
Mizuho Securities Remains a Buy on Healthequity (HQY)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Healthequity

3 Months
David LarsenBTIG
Success Rate
13/19 ratings generated profit
68%
Average Return
+5.14%
Copying David Larsen's trades and holding each position for 3 Months would result in 68.42% of your transactions generating a profit, with an average return of +5.14% per trade.
1 Year
Sean DodgeBMO Capital
Success Rate
20/26 ratings generated profit
77%
Average Return
+9.35%
Copying Sean Dodge's trades and holding each position for 1 Year would result in 76.92% of your transactions generating a profit, with an average return of +9.35% per trade.
2 Years
Sean DodgeBMO Capital
Success Rate
21/26 ratings generated profit
81%
Average Return
+24.80%
Copying Sean Dodge's trades and holding each position for 2 Years would result in 80.77% of your transactions generating a profit, with an average return of +24.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HQY Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
2
7
8
7
Buy
15
18
17
13
18
Hold
2
2
1
1
0
Sell
1
1
1
0
1
Strong Sell
0
0
0
0
0
total
18
23
26
22
26
In the current month, HQY has received 25 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. HQY average Analyst price target in the past 3 months is 114.27.
Each month's total comprises the sum of three months' worth of ratings.

HQY Financial Forecast

HQY Earnings Forecast

Next quarter’s earnings estimate for HQY is $1.19 with a range of $1.14 to $1.23. The previous quarter’s EPS was $1.24. HQY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HQY has Performed in-line its overall industry.
Next quarter’s earnings estimate for HQY is $1.19 with a range of $1.14 to $1.23. The previous quarter’s EPS was $1.24. HQY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year HQY has Performed in-line its overall industry.

HQY Sales Forecast

Next quarter’s sales forecast for HQY is $348.63M with a range of $342.20M to $351.81M. The previous quarter’s sales results were $354.44M. HQY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HQY has Performed in-line its overall industry.
Next quarter’s sales forecast for HQY is $348.63M with a range of $342.20M to $351.81M. The previous quarter’s sales results were $354.44M. HQY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year HQY has Performed in-line its overall industry.

HQY Stock Forecast FAQ

What is HQY’s average 12-month price target, according to analysts?
Based on analyst ratings, Healthequity Inc’s 12-month average price target is 114.27.
    What is HQY’s upside potential, based on the analysts’ average price target?
    Healthequity Inc has 32.81% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HQY a Buy, Sell or Hold?
          Healthequity Inc has a consensus rating of Strong Buy which is based on 10 buy ratings, 0 hold ratings and 1 sell ratings.
            What is Healthequity Inc’s price target?
            The average price target for Healthequity Inc is 114.27. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $128.00 ,the lowest forecast is $88.00. The average price target represents 32.81% Increase from the current price of $86.04.
              What do analysts say about Healthequity Inc?
              Healthequity Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of HQY?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.